Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €276.60 | €445.58 | 61.093% |
| Chemed Corp. | 5 | 0 | 1 | 0 | €535.00 | €588.14 | 9.933% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €213.80 | €248.57 | 16.263% |
| Haemonetics Corp. | 8 | 0 | 1 | 0 | €89.50 | €98.31 | 9.839% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €98.16 | - | - |
| Repligen Corp. | 13 | 0 | 1 | 0 | €161.85 | €184.76 | 14.155% |
| Korian S.A. | 1 | 0 | 1 | 0 | €3.40 | - | - |
| Amedisys Inc. | 14 | 0 | 1 | 0 | €87.00 | €92.26 | 6.046% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €9.83 | €20.35 | 107.039% |
| Masimo Corp. | 7 | 1 | 1 | 0 | €106.75 | €147.62 | 38.282% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.00 | - | - |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €110.00 | €116.99 | 6.357% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €23.02 | €52.03 | 125.999% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €77.00 | €75.94 | -1.382% |
| Insulet Corp. | 16 | 0 | 2 | 0 | €165.95 | €215.54 | 29.881% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €32.40 | €38.99 | 20.335% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €42.13 | €50.33 | 19.470% |
| Amicus Therapeutics Inc. | 6 | 0 | 3 | 0 | €8.90 | €17.78 | 99.766% |
| Icon plc | 18 | 0 | 3 | 0 | €295.70 | €319.67 | 8.106% |
| Select Medical Holdings | 6 | 0 | 3 | 0 | €32.20 | €36.41 | 13.064% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €373.30 | €421.61 | 12.940% |
| United Therapeutics | 18 | 0 | 3 | 0 | €250.60 | €288.66 | 15.188% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.42 | €26.01 | 33.950% |
| LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |